LSU Health discovers critical role of two proteins in vision and preventing blinding eye diseases

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

December 10, 2019

Genetics Retina

Basic Research

Grantee

LSU researchers have discovered unique patterns of genetic activity that may lead to the development of blinding retinal diseases. They report the discovery of novel gene signatures leading to mutations in two proteins – MFRP, which participates in cell fate and development, and Adipor1, whose absence in the retina results in the inability to take up and incorporate the building block docosahexaenoic acid (DHA 22:6) and the onset of retinal degeneration.